Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   Open-label, non-rando'd, multicntr Ph I study to determine max tolerated and/or recomm'd Ph II dose of oral mutant IDH1 (mIDH1) inhibitor BAY1436032 and characterize safety, tolerability, PK, PD, and prelim clin efficacy in pts w/mIDH1-R132X advanced AML
Disease/Condition   Blood and Bone Marrow Cancer,Blood Disorders and Diseases,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Leukemia

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Ioannis Mantzaris, MD
Contact Name   Kailashben Thummar
Contact Email
Protocol Number   17-06-73-01
Inclusion/Notes   This information was obtained from
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Myeloid and Monocytic Leukemia